Similar articles

• In vivo high-efficiency transcoronary gene delivery and Cre-LoxP gene switching in the adult mouse heart.

  Iwatate M, Gu Y, Dieterle T, Iwanaga Y, Peterson KL, Hoshijima M, Chien KR, Ross J. Iwatate M, et al. Gene Ther. 2003 Oct;10(21):1814-20. doi: 10.1038/sj.gt.3302077. Gene Ther. 2003. PMID: 12960971
• A newly modified SCG10 promoter and Cre/loxP-mediated gene amplification system achieve highly specific neuronal expression in animal brains.

  Namikawa K, Murakami K, Okamoto T, Okado H, Kiyama H. Namikawa K, et al. Gene Ther. 2006 Aug;13(16):1244-50. doi: 10.1038/sj.gt.3302779. Epub 2006 Apr 20. Gene Ther. 2006. PMID: 16625241
• Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element.

  Jaakkola P, Ahonen M, Kähäri VM, Jalkanen M. Jaakkola P, et al. Gene Ther. 2000 Oct;7(19):1640-7. doi: 10.1038/sj.gt.3301293. Gene Ther. 2000. PMID: 11083472
• Gene therapy progress and prospects: viral trafficking during infection.

  Campbell EM, Hope TJ. Campbell EM, et al. Gene Ther. 2005 Sep;12(18):1353-9. doi: 10.1038/sj.gt.3302585. Gene Ther. 2005. PMID: 16151445 Review.
• Gutless adenovirus: last-generation adenovirus for gene therapy.

  Alba R, Bosch A, Chillon M. Alba R, et al. Gene Ther. 2005 Oct;12 Suppl 1:S18-27. doi: 10.1038/sj.gt.3302612. Gene Ther. 2005. PMID: 16231052 Review.